Search by Drug Name or NDC
NDC 00031-9306-01 Robitussin Medi-Soothers 5; 5 mg/1; mg/1 Details
Robitussin Medi-Soothers 5; 5 mg/1; mg/1
Robitussin Medi-Soothers is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL, UNSPECIFIED FORM.
Product Information
| NDC | 00031-9306 |
|---|---|
| Product ID | 0031-9306_6bec225e-a203-4866-b0db-b76f73a6ae25 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Robitussin Medi-Soothers |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dextromethorphan hydrobromide, menthol |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LOZENGE |
| Route | ORAL |
| Active Ingredient Strength | 5; 5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL, UNSPECIFIED FORM |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00031-9306-01 (00031930601)
| NDC Package Code | 0031-9306-01 |
|---|---|
| Billing NDC | 00031930601 |
| Package | 8 LOZENGE in 1 BLISTER PACK (0031-9306-01) |
| Marketing Start Date | 2023-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |